欢迎来到天天文库
浏览记录
ID:54979643
大小:313.97 KB
页数:4页
时间:2020-05-07
《扶正补虚方对原发性肝癌患者细胞免疫功能及生活质量的影响-论文.pdf》由会员上传分享,免费在线阅读,更多相关内容在行业资料-天天文库。
1、第22卷第8期第444页中国中西医结合消化杂志Vo122No8P4442014年8月ChinJIntegrTradWestMedDigAug2014doi:10.3969/j.issn.1671—038X.2014.08.08扶正补虚方对原发性肝癌患者细胞免疫功能及生活质量的影响胡文雷,徐焕海(乐清市人民医院中西医结合科,浙江乐清325601;乐清市人民医院消化内科,浙江乐清325601)摘要:[目的]探讨扶正补虚方治疗原发性肝癌的疗效及应用价值。[方法]选择我院治疗的原发性肝癌患者58例,随机分为
2、观察组和对照组。对照组采用常规治疗,观察组在对照组基础上联合使用扶正补虚方剂治疗,观察2组的治疗情况。[结果]观察组治疗总有效率为55.17,对照组的总有效率为27.59,组问比较差异有统计学意义(P3、D4/CD8(1.56±0.66),改善幅度优于对照组,同对照组治疗后比较差异有统计学意义(;5.1410、5.3073、6.2669、3.0764,P<0.05)。[结论]在常规治疗基础上给予患者扶正补虚方剂治疗能够提高治疗效果,改善患者生存质量,提高患者免疫功能,值得临床推广使用。关键词:扶正补虚I肝癌;原发性;免疫功能;生活质量中图分类号:R735.7文献标志码:A文章编号:1671038X(2014)08—0444—04TheclinicaleffectsofFuzhengbuxudecoc4、tiononthecellularimmunefunctionandlifequalityofpatientswithprimarylivercancerHUWPT/一Z,XUHuan—hai(DepartmentofIntegratedTCM&WesternMedicine,ThePeople’sHospitalofYueqing,Yueqing325601,China;DepartmentofGastroenterology,ThePeople’8HospitalofYueqing,Yueqin5、g325601,China)Abstract:I-oNiective]ToexploretheeffectandapplicationvalueofFuzhengbuxudecoction(FD)intreatingprimarylivercancerI-Methods]Fifty—eightpatientswithprimarylivercancerwererandomlydivid——edintoobservationgroupandcontrolgroup,administeredwithco6、nventionaltreatmentincombinationwithFDandconventionaltreatmentrespectively.Lifequalityandimmunefunctionwereobservedinthetwogroups.[Results]Totaleffectiverateoftheobservationgroupandthecontrolgroupwas55.17and27.59respectively.Thedifferencebetweenthegrou7、pswasstatisticallysignificant(P<0.05).TCMsymptomscoreoftheobservationgroupaftertreatmentwas(3.15±0.56),andthescoreoflifequalitywas(78.26±6.84).Comparedtothatofthecontrolgroupaftertreatment,therewasstatisticallysignificantdifference(t=19.2497,4.7436;P<08、.05).ObservationgroupaftertreatmenthadanimprovementinCD3(64.02±7.65),CD4(40.71±7.17),andCD8(23.744-3.97),CD4/CD8(1.56+0.66),whichwasbetterthanthecontrolgroup.andthedifferencewasalsostatisticallysignificant(t一5.1410,5.3073,6.2669,5.3073;
3、D4/CD8(1.56±0.66),改善幅度优于对照组,同对照组治疗后比较差异有统计学意义(;5.1410、5.3073、6.2669、3.0764,P<0.05)。[结论]在常规治疗基础上给予患者扶正补虚方剂治疗能够提高治疗效果,改善患者生存质量,提高患者免疫功能,值得临床推广使用。关键词:扶正补虚I肝癌;原发性;免疫功能;生活质量中图分类号:R735.7文献标志码:A文章编号:1671038X(2014)08—0444—04TheclinicaleffectsofFuzhengbuxudecoc
4、tiononthecellularimmunefunctionandlifequalityofpatientswithprimarylivercancerHUWPT/一Z,XUHuan—hai(DepartmentofIntegratedTCM&WesternMedicine,ThePeople’sHospitalofYueqing,Yueqing325601,China;DepartmentofGastroenterology,ThePeople’8HospitalofYueqing,Yueqin
5、g325601,China)Abstract:I-oNiective]ToexploretheeffectandapplicationvalueofFuzhengbuxudecoction(FD)intreatingprimarylivercancerI-Methods]Fifty—eightpatientswithprimarylivercancerwererandomlydivid——edintoobservationgroupandcontrolgroup,administeredwithco
6、nventionaltreatmentincombinationwithFDandconventionaltreatmentrespectively.Lifequalityandimmunefunctionwereobservedinthetwogroups.[Results]Totaleffectiverateoftheobservationgroupandthecontrolgroupwas55.17and27.59respectively.Thedifferencebetweenthegrou
7、pswasstatisticallysignificant(P<0.05).TCMsymptomscoreoftheobservationgroupaftertreatmentwas(3.15±0.56),andthescoreoflifequalitywas(78.26±6.84).Comparedtothatofthecontrolgroupaftertreatment,therewasstatisticallysignificantdifference(t=19.2497,4.7436;P<0
8、.05).ObservationgroupaftertreatmenthadanimprovementinCD3(64.02±7.65),CD4(40.71±7.17),andCD8(23.744-3.97),CD4/CD8(1.56+0.66),whichwasbetterthanthecontrolgroup.andthedifferencewasalsostatisticallysignificant(t一5.1410,5.3073,6.2669,5.3073;
此文档下载收益归作者所有